2023-07-27
LION™-formulated repRNA vaccination exhibited a significant safety profile, along with enhanced efficacy and biodistribution response when compared to lipid nanoparticle (LNP)-formulated repRNA vaccines in mice. Study findings, published in the peer-reviewed journal Molecular Therapy, suggest repRNA and LION has potential as a next-generation vaccine platform technology.
